Lisinopril 10 mg tablet
Public data on lisinopril from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
NADAC per unit, monthly
LISINOPRIL 10 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.02215 |
| 2014-02 | 0.02257 |
| 2014-05 | 0.02039 |
| 2014-08 | 0.02083 |
| 2014-11 | 0.02003 |
| 2015-02 | 0.01977 |
| 2015-05 | 0.01906 |
| 2015-08 | 0.01876 |
| 2015-11 | 0.01831 |
| 2016-02 | 0.01922 |
| 2016-05 | 0.01872 |
| 2016-08 | 0.01997 |
| 2016-11 | 0.01881 |
| 2017-02 | 0.01813 |
| 2017-05 | 0.01599 |
| 2017-08 | 0.01732 |
| 2017-11 | 0.01766 |
| 2018-02 | 0.01743 |
| 2018-05 | 0.01707 |
| 2018-08 | 0.01749 |
| 2018-11 | 0.01654 |
| 2019-02 | 0.01691 |
| 2019-05 | 0.01889 |
| 2019-08 | 0.02019 |
| 2019-11 | 0.02089 |
| 2020-02 | 0.02128 |
| 2020-05 | 0.02257 |
| 2020-08 | 0.02350 |
| 2020-11 | 0.02228 |
| 2021-02 | 0.02192 |
| 2021-05 | 0.02145 |
| 2021-08 | 0.02216 |
| 2021-11 | 0.02133 |
| 2022-02 | 0.01956 |
| 2022-05 | 0.01922 |
| 2022-08 | 0.01974 |
| 2022-11 | 0.01902 |
| 2023-02 | 0.01907 |
| 2023-05 | 0.01823 |
| 2023-08 | 0.01906 |
| 2023-11 | 0.01838 |
| 2024-02 | 0.01828 |
| 2024-05 | 0.01617 |
| 2024-08 | 0.01684 |
| 2024-11 | 0.01745 |
| 2025-02 | 0.01744 |
| 2025-05 | 0.01828 |
| 2025-08 | 0.01849 |
| 2025-11 | 0.01855 |
| 2026-02 | 0.01887 |
| 2026-05 | 0.01885 |
| 2026-08 | 0.01849 |
| 2026-11 | 0.01797 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning lisinopril
openFDA enforcement records, by year reported.
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 2 |
| 2020 | 5 |
| 2019 | 2 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 4 |
| 2015 | 14 |
41 records since 2012. A record is one product or lot, not one recall event. Combination products that contain lisinopril are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention lisinopril
32 GxRadar articles cite or discuss this drug.
What pharmacies pay for seven blood pressure generics, 2014 and 2026
At federal survey rates, 365 tablets each of seven common blood pressure generics cost pharmacies about $95 in October 2026, down from $1,403 in October 2014. One drug explains most of the drop.
What a generic must share with its brand, and what can differ
FDA fixes a generic's active ingredient, strength, form, route and absorption. Fillers, dyes, shape and price can vary. How the rules work, and how to look up one product's ingredients on DailyMed.
Why the same generic costs different amounts at different pharmacies
Cash quotes for the same three heart-failure generics ranged from $12 to almost $398 across 175 pharmacies in one 2016 study. Federal cost data show how little of that price is the drug itself.
What pharmacies pay for a month of common generics
Thirty tablets of each of the 10 most-used generics we track cost pharmacies $35.70 in January 2014 and $8.80 in October 2026. That is acquisition cost, and the rest of the price sits on top of it.
How to ask for the cash price at the pharmacy
Two 2018 federal laws let pharmacists tell you when paying without insurance costs less. What the laws say, what pharmacies pay for common generics, and the questions that get you both prices.
How pharmacy dispensing fees work
Medicaid pays pharmacies a per-prescription fee built from state cost surveys, mostly $10 to $11 in 2026. Medicare drug plans negotiate their own, which federal advisers describe as typically a fixed amount such as $1.